UNSPSC 51381908: Oxolamine hydrochloride

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H19N3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SHI14LG2ZY, chemically known as 1,2,4-oxadiazole, 5-(2-(diethylamino)ethyl)-3-phenyl-, monohydrochloride, but more generally known as oxolamine hydrochloride, which bears US NIH Compound Identifier 14637. European Medicines Agency schedules oxolamine hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09547MIG.

Most nations, for tariff purposes, schedule oxolamine hydrochloride under HS 29349990. SMILES: CCN(CC)CCC1NC(NO1)C2CCCCC2.CL.

UNSPSC 51381908 Oxolamine hydrochloride is a Commodity code that in recent state and local procurement appears to encompass pharmaceutical products and drug-related medical supplies rather than oxolamine specifically. Seminole County, Florida's recent IFB solicitation for naloxone and safe drug deactivation systems shows that the code is being applied to public health procurement where county governments and local health agencies buy opioid-overdose reversal medications and related pharmaceutical support equipment to support community health initiatives and emergency response. The scope of work involves competitive procurement of finished pharmaceutical products with specific annual unit quantities, quarterly delivery schedules to designated health facilities, and vendor compliance with drug-free workplace certification, E-Verify requirements, workers' compensation and commercial general liability insurance, and federal regulations including the Clean Air Act and Federal Water Pollution Control Act.

Seminole County, Florida represents the only recent state-local opportunity identified under this code. The county issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid response deadline was July 26, 2023, at 2:00 pm. The contract structure includes a two-year initial term with a one-year renewal option, fixed-fee pricing, and a three-month probationary termination period. Potential FEMA funding introduces additional federal compliance scrutiny. The code shows minimal recent activity, and the single opportunity on file indicates a mismatch between the code's nominal pharmaceutical name and the actual health-supplies procurement being tagged under it.